HK1073070A1 - Novel biomaterials, their preparation and use - Google Patents
Novel biomaterials, their preparation and useInfo
- Publication number
- HK1073070A1 HK1073070A1 HK05105740.7A HK05105740A HK1073070A1 HK 1073070 A1 HK1073070 A1 HK 1073070A1 HK 05105740 A HK05105740 A HK 05105740A HK 1073070 A1 HK1073070 A1 HK 1073070A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- novel biomaterials
- biomaterials
- novel
- Prior art date
Links
- 239000012620 biological material Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02008809 | 2002-04-19 | ||
PCT/EP2003/004076 WO2003089008A1 (en) | 2002-04-19 | 2003-04-17 | Novel biomaterials, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1073070A1 true HK1073070A1 (en) | 2005-09-23 |
Family
ID=29225593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05105740.7A HK1073070A1 (en) | 2002-04-19 | 2005-07-07 | Novel biomaterials, their preparation and use |
Country Status (20)
Country | Link |
---|---|
US (3) | US20050163853A1 (pt) |
EP (1) | EP1499361B1 (pt) |
JP (1) | JP4648632B2 (pt) |
KR (1) | KR101121675B1 (pt) |
CN (1) | CN1646171B (pt) |
AU (1) | AU2003224099B2 (pt) |
BR (1) | BR0309340A (pt) |
CA (1) | CA2484100C (pt) |
CO (1) | CO5611168A2 (pt) |
ES (1) | ES2392964T3 (pt) |
HK (1) | HK1073070A1 (pt) |
IL (1) | IL164627A (pt) |
MX (1) | MXPA04010325A (pt) |
NO (1) | NO20044979L (pt) |
NZ (1) | NZ535810A (pt) |
PL (1) | PL215579B1 (pt) |
PT (1) | PT1499361E (pt) |
RU (1) | RU2321597C2 (pt) |
WO (1) | WO2003089008A1 (pt) |
ZA (1) | ZA200407794B (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
CN100548271C (zh) | 2004-01-20 | 2009-10-14 | 阿勒根公司 | 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物 |
WO2006011044A1 (en) * | 2004-07-22 | 2006-02-02 | Pfizer Products Inc. | Amorphous cyclodextrin compositions |
US8246949B2 (en) * | 2004-10-27 | 2012-08-21 | Aciont, Inc. | Methods and devices for sustained in-vivo release of an active agent |
EP1787658B1 (en) | 2005-11-10 | 2012-03-14 | CHEMI S.p.A. | Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
WO2008029685A1 (fr) * | 2006-09-04 | 2008-03-13 | National Institute Of Advanced Industrial Science And Technology | Procédé pour analyse d'échantillon par électrophorèse capillaire |
US20100155242A1 (en) * | 2006-09-04 | 2010-06-24 | Arkray, Inc. | Method of Analyzing a Sample by Capillary Electrophoresis |
EP2060912B1 (en) * | 2006-09-04 | 2014-10-01 | National Institute of Advanced Industrial Science and Technology | Method for analysis of sample by capillary electrophoresis |
JP2009186445A (ja) * | 2008-02-08 | 2009-08-20 | Arkray Inc | キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬 |
ES2525257T3 (es) * | 2009-02-25 | 2014-12-19 | Supratek Pharma, Inc. | Composiciones de ciclopolisacárido y de bendamustina |
US20110015245A1 (en) * | 2009-07-20 | 2011-01-20 | Valery Alakhov | Bendamustine amphiphilic cationic compositions |
US8389558B2 (en) * | 2009-07-20 | 2013-03-05 | Supratek Pharma Inc. | Bendamustine amphiphilic anionic compositions |
EP2918178A1 (en) | 2010-03-13 | 2015-09-16 | Eastpond Laboratories Limited | Fat-binding compositions |
US8383663B2 (en) | 2010-07-19 | 2013-02-26 | Supratek Pharma Inc. | Bendamustine anionic-catioinic cyclopolysaccharide compositions |
JP2014502612A (ja) | 2010-12-31 | 2014-02-03 | イーストポンド・ラボラトリーズ・リミテッド | シクロデキストリンを含有する細胞水和組成物 |
US20120171184A1 (en) | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
WO2012107390A1 (en) | 2011-02-10 | 2012-08-16 | Unilever Nv | Antimicrobial composition |
WO2013109930A1 (en) | 2012-01-18 | 2013-07-25 | Surmodics, Inc. | Lubricious medical device coating with low particulates |
EP3569226A1 (en) * | 2012-12-04 | 2019-11-20 | Phosphorex, Inc. | Microparticles and nanoparticles having negative surface charges |
EP2996690A4 (en) * | 2013-05-17 | 2017-05-10 | Marquette University | Composite materials containing structural polysaccharides and macrocyclic compounds formed from ionic liquid compositions |
JP5673756B2 (ja) * | 2013-08-20 | 2015-02-18 | 東洋紡株式会社 | 医療用材料 |
RU2597085C2 (ru) * | 2013-11-07 | 2016-09-10 | Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) | Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты) |
WO2016206738A1 (en) | 2015-06-24 | 2016-12-29 | Kao Germany Gmbh | Hair treatment process |
US10342898B2 (en) * | 2015-12-29 | 2019-07-09 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US11174447B2 (en) | 2015-12-29 | 2021-11-16 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
DK3528856T3 (da) | 2016-10-18 | 2023-10-16 | Univ Marquette | Kompositmaterialer, der indeholder strukturelle polymerer og fotoreaktive nitrogenoxidfrigørende midler og anvendelser deraf til sårbandager |
MX2022012532A (es) | 2020-04-06 | 2023-03-15 | Eastpond Laboratories Ltd | Composiciones y métodos para promover la hidratación celular. |
CN114344557A (zh) * | 2022-01-10 | 2022-04-15 | 山东万容生物科技有限公司 | 一种含环糊精的水胶体敷料及其制备方法 |
WO2023212740A1 (en) * | 2022-04-29 | 2023-11-02 | Drexel University | Surfactant-impregnated mof-coated fabric for antimicrobial applications |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE670837A (pt) * | 1964-10-14 | 1966-01-31 | ||
JPS61251616A (ja) * | 1985-04-30 | 1986-11-08 | Agency Of Ind Science & Technol | 溶質の放出量の制御方法 |
JPS6416728A (en) * | 1987-07-07 | 1989-01-20 | Santen Pharmaceutical Co Ltd | Aqueous preparation |
JPH03234770A (ja) * | 1990-02-09 | 1991-10-18 | Nippon Shokubai Kagaku Kogyo Co Ltd | 電気刺激応答性ゲルの製法 |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
SE9303627D0 (sv) * | 1993-11-03 | 1993-11-03 | Kabi Pharmacia Ab | Method and means for prevention of cataract |
JPH08134134A (ja) * | 1994-11-09 | 1996-05-28 | Nippon Shokubai Co Ltd | 粒子状含水ゲル重合体の乾燥方法 |
JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
JPH0995413A (ja) * | 1995-09-29 | 1997-04-08 | Shiseido Co Ltd | 皮膚外用剤 |
GB9718568D0 (en) * | 1997-09-03 | 1997-11-05 | Chauvin Pharmaceuticals Limite | Compositions |
WO2000004916A1 (en) * | 1998-07-23 | 2000-02-03 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Encapsulation of water soluble peptides |
US6482942B1 (en) * | 1999-01-12 | 2002-11-19 | Biotechnology Services And Consulting, Inc. | Method of isolating mucilaginous polysaccharides and uses thereof |
JP2001318350A (ja) * | 2000-05-11 | 2001-11-16 | Lion Corp | コンタクトレンズ用溶液 |
ES2292586T3 (es) * | 2000-05-15 | 2008-03-16 | THE PROCTER & GAMBLE COMPANY | Composiciones que comprenden ciclodextrina. |
US20020147232A1 (en) * | 2000-05-26 | 2002-10-10 | Claus Sundgreen | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
-
2003
- 2003-04-17 US US10/511,075 patent/US20050163853A1/en not_active Abandoned
- 2003-04-17 AU AU2003224099A patent/AU2003224099B2/en not_active Ceased
- 2003-04-17 NZ NZ535810A patent/NZ535810A/en not_active IP Right Cessation
- 2003-04-17 KR KR1020047016698A patent/KR101121675B1/ko not_active IP Right Cessation
- 2003-04-17 BR BR0309340-9A patent/BR0309340A/pt not_active IP Right Cessation
- 2003-04-17 MX MXPA04010325A patent/MXPA04010325A/es active IP Right Grant
- 2003-04-17 CN CN038088592A patent/CN1646171B/zh not_active Expired - Fee Related
- 2003-04-17 PL PL371595A patent/PL215579B1/pl unknown
- 2003-04-17 EP EP03720497A patent/EP1499361B1/en not_active Expired - Lifetime
- 2003-04-17 RU RU2004133887/04A patent/RU2321597C2/ru not_active IP Right Cessation
- 2003-04-17 PT PT03720497T patent/PT1499361E/pt unknown
- 2003-04-17 JP JP2003585759A patent/JP4648632B2/ja not_active Expired - Fee Related
- 2003-04-17 ES ES03720497T patent/ES2392964T3/es not_active Expired - Lifetime
- 2003-04-17 CA CA2484100A patent/CA2484100C/en not_active Expired - Fee Related
- 2003-04-17 WO PCT/EP2003/004076 patent/WO2003089008A1/en active Application Filing
-
2004
- 2004-09-28 ZA ZA200407794A patent/ZA200407794B/xx unknown
- 2004-10-14 IL IL164627A patent/IL164627A/en not_active IP Right Cessation
- 2004-10-26 CO CO04107397A patent/CO5611168A2/es active IP Right Grant
- 2004-11-16 NO NO20044979A patent/NO20044979L/no not_active Application Discontinuation
-
2005
- 2005-07-07 HK HK05105740.7A patent/HK1073070A1/xx unknown
-
2008
- 2008-07-24 US US12/178,934 patent/US20080299166A1/en not_active Abandoned
-
2011
- 2011-10-25 US US13/281,033 patent/US20120040901A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA04010325A (es) | 2005-06-08 |
EP1499361B1 (en) | 2012-08-08 |
JP4648632B2 (ja) | 2011-03-09 |
NO20044979L (no) | 2004-11-16 |
BR0309340A (pt) | 2005-03-08 |
PT1499361E (pt) | 2012-11-22 |
JP2005529879A (ja) | 2005-10-06 |
US20120040901A1 (en) | 2012-02-16 |
AU2003224099A1 (en) | 2003-11-03 |
CN1646171A (zh) | 2005-07-27 |
AU2003224099B2 (en) | 2006-11-09 |
US20050163853A1 (en) | 2005-07-28 |
US20080299166A1 (en) | 2008-12-04 |
CA2484100A1 (en) | 2003-10-30 |
PL371595A1 (en) | 2005-06-27 |
NZ535810A (en) | 2007-11-30 |
IL164627A (en) | 2009-11-18 |
WO2003089008A1 (en) | 2003-10-30 |
KR20040103968A (ko) | 2004-12-09 |
KR101121675B1 (ko) | 2012-03-13 |
ES2392964T3 (es) | 2012-12-17 |
CN1646171B (zh) | 2010-05-26 |
EP1499361A1 (en) | 2005-01-26 |
CA2484100C (en) | 2012-01-03 |
RU2321597C2 (ru) | 2008-04-10 |
RU2004133887A (ru) | 2005-10-20 |
ZA200407794B (en) | 2006-02-22 |
CO5611168A2 (es) | 2006-02-28 |
PL215579B1 (pl) | 2013-12-31 |
IL164627A0 (en) | 2005-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1073070A1 (en) | Novel biomaterials, their preparation and use | |
TWI371450B (en) | Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use | |
IL168102A0 (en) | Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents | |
EP1539941A4 (en) | ADZYMES AND THEIR USES | |
IL172222A0 (en) | Aryl-heteroaromatic products, compositions comprising them and use | |
EP1617807A4 (en) | SUBSTITUTED 1,4-DIAZEPINE AND ITS USES | |
HK1059229A1 (en) | Cartilage implant and preparation thereof | |
HK1074446A1 (en) | 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof | |
HK1081954A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
GB0114399D0 (en) | Substrates, biomaterials and methods | |
HUP0500871A3 (en) | 5-aryltetrazole compounds, compositions thereof and their use | |
AU2003296369A8 (en) | Imminoamines and preparation thereof | |
HUP0600238A3 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
AU2003217565A8 (en) | Polydioxaborines, their monomers and their preparation | |
AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
EP1517879A4 (en) | AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE | |
GB0228525D0 (en) | Polymers and their use | |
EP1660088A4 (en) | PYRIDOMORPHINANES, PYRIDAZINOMORPHINANES AND USE THEREOF | |
AU2003299336A8 (en) | Diphosphines, preparation and uses thereof | |
IL149851A0 (en) | Resistin binding proteins, their preparation and use | |
IL151980A0 (en) | Resistin binding proteins, their preparation and use | |
GB0229445D0 (en) | Process,composition and use | |
GB2420345B (en) | 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use | |
GB0326138D0 (en) | Polymers, their preparation and uses | |
AU2003219313A1 (en) | Chemokines and uses thereof |